Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01214200 · ClinicalTrials.gov registry record · NA

High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)

A NA study, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01214200: Completed NA study, sponsored by Philips Respironics.

NCT01214200 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01214200, a NA study, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients. The investigators believe that HINPPV, used at least 6 hours nocturnally over three months, will benefit the stable hypercapnic COPD patient through a reduction in the daytime partial pressure of carbon dioxide in arterial blood (PaCO2) levels.

Primary Outcome

Daytime PaCO2 levels assessed after using high intensity non-invasive positive pressure ventilation (HINPPV) are compared to the participants' baseline daytime PaCO2 levels.

Interventions

  • DEVICE Bilevel positive airway pressure (BiPAP)

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-08
Est. Completion 2012-12
Phase NA
Philips Respironics

35 total trials

What the finished NCT01214200 record still lists

NCT01214200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Bilevel positive airway pressure (BiPAP) is the first listed.

NCT01214200 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01214200 about?

NCT01214200 is a clinical study titled "High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)". The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients. The investigators believe that HINPPV, used at least 6 hours nocturnally over three months, will benefit the stable hypercapnic COPD ...

What is the current status of trial NCT01214200?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01214200?

The interventions under investigation include: Bilevel positive airway pressure (BiPAP) (DEVICE).

Who is sponsoring clinical trial NCT01214200?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01214200's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01214200, the US trial registry maintained by the National Library of Medicine. NCT01214200 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.